Richard Gaynor
Präsident bei NEON THERAPEUTICS, INC.
Vermögen: 959 828 $ am 30.04.2024
Profil
Richard Brian Gaynor is currently the Director at Alkermes, Inc., the Independent Director at Infinity Pharmaceuticals, Inc., the Director at The Damon Runyon Cancer Research Foundation, the Independent Director at Alkermes Plc, the Independent Director at Zai Lab Ltd., and the President and Head of Research & Development at BioNTech US, Inc. Previously, he served as the Director of Simmons Cancer Center at The University of Texas Southwestern Medical Center from 1998 to 2002.
He was also the Director and Chief of Hematology at Harold C Simmons Comprehensive Cancer Center.
From 2002 to 2016, he worked at Eli Lilly & Co. as the Vice President of Clinical Development and later as the Senior Vice President and Head of Clinical Development & Medical Affairs at Lilly Oncology.
Dr. Gaynor received his undergraduate degree from Texas Tech University and his doctorate from The University of Texas Southwestern Medical Center.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 07.07.2023 | 20 356 ( 0,01% ) | 497 501 $ | 30.04.2024 | |
ZAI LAB LTD.
0,03% | 12.04.2024 | 278 150 ( 0,03% ) | 462 327 $ | 30.04.2024 |
| 30.05.2023 | 0 ( -.--% ) | - $ | 31.01.2024 |
Aktive Positionen von Richard Gaynor
| Unternehmen | Position | Beginn |
|---|---|---|
| NEON THERAPEUTICS, INC. | Präsident | 01.05.2020 |
| ALKERMES PLC | Direktor/Vorstandsmitglied | 12.09.2019 |
| INFINITY PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 16.03.2020 |
| ZAI LAB LIMITED | Direktor/Vorstandsmitglied | 19.11.2021 |
The Damon Runyon Cancer Research Foundation
 The Damon Runyon Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services The Damon Runyon Cancer Research Foundation supports cancer research through grants to scientists in fields including cellular biology, genetics, immunology, and virology. It was founded in 1946 and is headquartered in New York City, NY. | Direktor/Vorstandsmitglied | - |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Direktor/Vorstandsmitglied | 01.09.2019 |
Ehemalige bekannte Positionen von Richard Gaynor
| Unternehmen | Position | Ende |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.10.2016 |
| The University of Texas Southwestern Medical Center | Corporate Officer/Principal | 01.08.2002 |
Lilly Oncology
 Lilly Oncology Hospital/Nursing ManagementHealth Services Part of Eli Lilly & Co., Lilly Oncology is an American company dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. With over 50 years of experience, Lilly Oncology is committed to building on their heritage and improving the lives of all those affected by cancer worldwide. | Corporate Officer/Principal | - |
| ░░░░░░ ░ ░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Richard Gaynor
| The University of Texas Southwestern Medical Center | Doctorate Degree |
| Texas Tech University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| ALKERMES PLC | Health Technology |
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| ZAI LAB LIMITED | Health Technology |
| Private Unternehmen | 5 |
|---|---|
BioNTech US, Inc.
 BioNTech US, Inc. BiotechnologyHealth Technology BioNTech US, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. The company was founded by James P. Allison, Edward J. Fritsch, Nir Hacohen, Eric S. Lander, Robert Schreiber, Ton Schumacher and Catherine Wu on October 21, 2013 and is headquartered in Cambridge, MA. | Health Technology |
| Harold C Simmons Comprehensive Cancer Center | |
The Damon Runyon Cancer Research Foundation
The Damon Runyon Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services The Damon Runyon Cancer Research Foundation supports cancer research through grants to scientists in fields including cellular biology, genetics, immunology, and virology. It was founded in 1946 and is headquartered in New York City, NY. | Commercial Services |
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
Lilly Oncology
Lilly Oncology Hospital/Nursing ManagementHealth Services Part of Eli Lilly & Co., Lilly Oncology is an American company dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. With over 50 years of experience, Lilly Oncology is committed to building on their heritage and improving the lives of all those affected by cancer worldwide. | Health Services |
